115 related articles for article (PubMed ID: 35331723)
1. Novel vandetanib derivative inhibited proliferation and promoted apoptosis of cancer cells under normoxia and hypoxia.
Yin L; Zhan J; Liao H; Qiu W; Hou W; Li S; Zhang J
Eur J Pharmacol; 2022 May; 922():174907. PubMed ID: 35331723
[TBL] [Abstract][Full Text] [Related]
2. Lenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1α and -2α and vascular endothelial growth factor in lens epithelial cell survival in hypoxia.
Neelam S; Brooks MM; Cammarata PR
Mol Vis; 2013; 19():1-15. PubMed ID: 23335846
[TBL] [Abstract][Full Text] [Related]
3. Design and Synthesis of Vandetanib Derivatives Containing Nitroimidazole Groups as Tyrosine Kinase Inhibitors in Normoxia and Hypoxia.
Wei H; Li D; Yang X; Shang H; Fan S; Li Y; Song D
Molecules; 2016 Dec; 21(12):. PubMed ID: 27983649
[TBL] [Abstract][Full Text] [Related]
4. Q39, a novel synthetic Quinoxaline 1,4-Di-N-oxide compound with anti-cancer activity in hypoxia.
Weng Q; Wang D; Guo P; Fang L; Hu Y; He Q; Yang B
Eur J Pharmacol; 2008 Mar; 581(3):262-9. PubMed ID: 18215659
[TBL] [Abstract][Full Text] [Related]
5. Effects of EGCG on proliferation and apoptosis of gastric cancer SGC7901 cells via down-regulation of HIF-1α and VEGF under a hypoxic state.
Fu JD; Yao JJ; Wang H; Cui WG; Leng J; Ding LY; Fan KY
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):155-161. PubMed ID: 30657557
[TBL] [Abstract][Full Text] [Related]
6. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy.
Secades P; de Santa-María IS; Merlo A; Suarez C; Chiara MD
Head Neck; 2015 Aug; 37(8):1150-62. PubMed ID: 24798801
[TBL] [Abstract][Full Text] [Related]
7. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
8. Combining the multitargeted tyrosine kinase inhibitor vandetanib with the antiestrogen fulvestrant enhances its antitumor effect in non-small cell lung cancer.
Siegfried JM; Gubish CT; Rothstein ME; Henry C; Stabile LP
J Thorac Oncol; 2012 Mar; 7(3):485-95. PubMed ID: 22258476
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression.
Peng XH; Karna P; Cao Z; Jiang BH; Zhou M; Yang L
J Biol Chem; 2006 Sep; 281(36):25903-14. PubMed ID: 16847054
[TBL] [Abstract][Full Text] [Related]
10. ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway.
Wang XJ; Feng CW; Li M
Mol Cell Biochem; 2013 Aug; 380(1-2):57-66. PubMed ID: 23625205
[TBL] [Abstract][Full Text] [Related]
11. The Apoptotic Effect of HIF-1α Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions.
Tanaka T; Kitajima Y; Miyake S; Yanagihara K; Hara H; Nishijima-Matsunobu A; Baba K; Shida M; Wakiyama K; Nakamura J; Noshiro H
PLoS One; 2015; 10(9):e0137257. PubMed ID: 26339797
[TBL] [Abstract][Full Text] [Related]
12. Melatonin restricts the viability and angiogenesis of vascular endothelial cells by suppressing HIF-1α/ROS/VEGF.
Cheng J; Yang HL; Gu CJ; Liu YK; Shao J; Zhu R; He YY; Zhu XY; Li MQ
Int J Mol Med; 2019 Feb; 43(2):945-955. PubMed ID: 30569127
[TBL] [Abstract][Full Text] [Related]
13. Ursolic acid sensitized colon cancer cells to chemotherapy under hypoxia by inhibiting MDR1 through HIF-1α.
Shan JZ; Xuan YY; Zhang Q; Huang JJ
J Zhejiang Univ Sci B; 2016 Sep; 17(9):672-82. PubMed ID: 27604859
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells.
Sarkar S; Rajput S; Tripathi AK; Mandal M
Mol Cancer; 2013 Oct; 12(1):122. PubMed ID: 24138843
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of hypoxia-inducible factor 1alpha on the biological characteristics of the SiHa uterine cervix cancer cell line.
Tang B; Qu Y; Zhao F; Mao M; Tang J; Li X; Ferriero D; Mu D
Int J Gynecol Cancer; 2009 Jul; 19(5):898-904. PubMed ID: 19574782
[TBL] [Abstract][Full Text] [Related]
16. Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance.
Naumov GN; Nilsson MB; Cascone T; Briggs A; Straume O; Akslen LA; Lifshits E; Byers LA; Xu L; Wu HK; Jänne P; Kobayashi S; Halmos B; Tenen D; Tang XM; Engelman J; Yeap B; Folkman J; Johnson BE; Heymach JV
Clin Cancer Res; 2009 May; 15(10):3484-94. PubMed ID: 19447865
[TBL] [Abstract][Full Text] [Related]
17. Sulforaphane blocks hypoxia-mediated resistance to TRAIL-induced tumor cell death.
Jeong JK; Moon MH; Seo JS; Seol JW; Lee YJ; Park SY
Mol Med Rep; 2011; 4(2):325-30. PubMed ID: 21468572
[TBL] [Abstract][Full Text] [Related]
18. [Influence of hypoxia inducible factor-1alpha on cervical cancer cell line HeLa in vitro].
Cheng YX; Pu DM; Liu R; Li T; Yin L; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):551-4. PubMed ID: 17983496
[TBL] [Abstract][Full Text] [Related]
19. [Effects of hypoxia inducible factor-1α on P311 and its influence on the migration of murine epidermal stem cells].
Xu ZD; Li HS; Wang S; He WF; Wu J; Luo GX
Zhonghua Shao Shang Za Zhi; 2017 May; 33(5):287-294. PubMed ID: 28651420
[No Abstract] [Full Text] [Related]
20. RNAi Knockdown of Hypoxia-Inducible Factor-1α Decreased the Proliferation, Migration, and Invasion of Hypoxic Hepatocellular Carcinoma Cells.
Chen C; Liu R; Wang J; Yan Z; Qian S; Zhang W
Cell Biochem Biophys; 2015 Apr; 71(3):1677-84. PubMed ID: 25388848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
